ERBB2 and cancer: The Cancer Genome Atlas Network observed the HR+/HER2− subtype harbored the most frequent mutations being PIK3CA, MAP3K1, and TP53; HER2+ subtype had a high frequency of TP53 and PIK3CA, and basal‐like cancers had a high frequency of TP53 mutations.21